AI assistant
BAXTER INTERNATIONAL INC — Director's Dealing 2021
Jun 25, 2021
30537_dirs_2021-06-25_4ea1b02e-7ba0-4691-a7dd-15ee7fe9d012.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Miromatrix Medical Inc. (MIRO)
CIK: 0001527096
Period of Report: 2021-06-24
Reporting Person: BAXTER INTERNATIONAL INC (10% Owner)
Reporting Person: BAXTER HEALTHCARE CORP (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-24 | Common Stock | C | 2083333 | — | Acquired | 2083333 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-24 | Series C Convertible Preferred Stock | $ | C | 2083333 | Disposed | Common Stock (2083333) | Indirect |
Footnotes
F1: The Series C Convertible Preferred Stock of Miromatrix Medical Inc. (the "Issuer") were automatically converted into 2,083,333 shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering (the "IPO") of its Common Stock, without payment of consideration. The 2,083,333 shares amount is based on the actual IPO price of $9.00 per share of Common Stock. The 2,343,750 shares amount previously reported on Form 3, dated 06/23/2021, was based on an assumed IPO price of $8.00 per share of Common Stock.
F2: The reported securities are owned directly by Baxter Healthcare Corporation, a wholly owned subsidiary of Baxter International Inc.